Evaluation of Therapeutic Effect of Unani Formulation in Scalp Psoriasis: A Case Series Study
Abstract
Introduction: Psoriasis is considered one of the most chronic inflammatory disorders of the skin which affects almost about 2% world’s population. Their prevalence is low among the Asian and African populations. It is a multifactorial disease that primarily affects the skin and later on joints. Plaques in the case of psoriasis are thick and scaly due to abnormal keratinisation and abnormal keratinisation is most commonly seen in the case of scalp involvement. The scalp is the most common region affected in psoriasis that’s why effective therapeutic regimens are essential for the management of scalp psoriasis. Scalp psoriasis is characterised by the presence of reddish and scaly patches which can spread to the neck, forehead, and behind the ears.
Objectives: Evaluation of Unani formulation as local application and Qushta Sadaf (calcium) as oral preparation in patients with scalp psoriasis.
Method: The observational clinical study was carried out on patients with scalp psoriasis. Patients are advised to apply Unani formulation over the scalp and calcium supplements once a day for 5 weeks. The assessment of efficacy was evaluated by a decrease in subjective parameters.
Results: The result was encouraging.
Conclusion: The applied Unani formulation as local application and calcium as oral preparations were found to be effective and safe in the management of scalp psoriasis. However further studies are needed to be carried out for a longer time with a larger sample size to rule efficacy of the Unani formulation.
How to cite this article:
Sultan N, Aleem S, Firdaus S, Shoaib M, Anas M. Evaluation of Therapeutic Effect of Unani Formulation in Scalp Psoriasis: A Case Series Study. J Integ Comm Health. 2021;10(2):18-21.
DOI: https://doi.org/10.24321/2319.9113.202108
References
Mosca M, Hong J, Hadeler E, Brownstone N, Bhutani T, Liao W.Scalp psoriasis: aliterature review of effective therapies and updated recommendations for practical management. Dermatol Ther (Heidelb). 2021 Jun;11(3):769-97. [PubMed] [Google Scholar]
Phiske MM. Scalp psoriasis: a brief overview. J Cosmo Trichol. 2016;2(2).
Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology e-book. 3rd ed. Elsevier Health Sciences; 2012.
Nasir N, Fatma G, Ali W, Ahmad M. Unani and modern aspects of psoriasis (Da’u-us-Sadaf) treatment: a review. Int J Res Dermatol. 2020 Jul;6(4):589-96.
Ahmad A. A critical review of Daus-Sadaf (Psoriasis): Unani & modern perspectives. Int J Creat Res Thoug. 2020;8(7):4570-82. [Google Scholar]
Mohsin M. Psoriasis (Dau-S-Sadaf) with reference to Unani medicine and modern medical updates. Asian J Tradit Complem Altern Med. 2020 Aug;3(1-2):40-54. [Google Scholar]
Siddiqui KM, Haq ME, Nawaz WS, Hassan S. Clinical efficacy of Unani medicine in psoriasis: a case series study. Integrative Med. 2017;1(2):4-6. [Google Scholar]
Ali J, Akhtar N, Sultana Y, Baboota S, Ahuja A. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol. 2008 May;30(4):277-85. [PubMed] [Google Scholar]
Khan MS, Siddiqui MM, Aleem S. Effect of Psoraliacorylifolia Linn. and Marham-e-Gulabi in Daal-sadaf (psoriasis). Int J Tradi Know. 2009;8:425-30. [Google Scholar]
Morimoto S, Yoshikawa K, Fukuo K, Shiraishi T, Koh E, Imanaka S, Kitano S, Ogihara T.Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level. J Dermatol Sci. 1990 Jul;1(4):277-82. [PubMed] [Google Scholar]
Zhai Z, Chen L, Yang H, Yan J, Wang C, Yang J, Liu W, Shen Z. Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis? J Am Acad Dermatol. 2015 Dec;73(6):991-7.e3. [PubMed] [Google Scholar]
